Cardinal Capital Management Purchases 8,959 Shares of Phibro Animal Health Co. (NASDAQ:PAHC)

Cardinal Capital Management raised its holdings in shares of Phibro Animal Health Co. (NASDAQ:PAHC) by 16.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 64,986 shares of the company’s stock after purchasing an additional 8,959 shares during the quarter. Cardinal Capital Management owned 0.16% of Phibro Animal Health worth $1,463,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. CWM LLC increased its position in shares of Phibro Animal Health by 89.8% during the second quarter. CWM LLC now owns 2,188 shares of the company’s stock worth $37,000 after acquiring an additional 1,035 shares in the last quarter. Fidelis Capital Partners LLC bought a new stake in Phibro Animal Health during the 1st quarter worth approximately $46,000. nVerses Capital LLC purchased a new stake in shares of Phibro Animal Health in the third quarter worth approximately $70,000. Summit Securities Group LLC purchased a new position in shares of Phibro Animal Health during the second quarter valued at approximately $83,000. Finally, Illinois Municipal Retirement Fund grew its holdings in Phibro Animal Health by 7.2% during the first quarter. Illinois Municipal Retirement Fund now owns 11,430 shares of the company’s stock worth $148,000 after buying an additional 765 shares in the last quarter. Institutional investors and hedge funds own 99.34% of the company’s stock.

Insider Buying and Selling at Phibro Animal Health

In other news, Director E Thomas Corcoran purchased 5,000 shares of the business’s stock in a transaction dated Wednesday, September 4th. The stock was bought at an average price of $20.02 per share, for a total transaction of $100,100.00. Following the purchase, the director now owns 25,000 shares of the company’s stock, valued at $500,500. The trade was a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 50.07% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on PAHC. Bank of America lifted their price objective on shares of Phibro Animal Health from $13.00 to $15.00 and gave the stock an “underperform” rating in a report on Friday, August 30th. JPMorgan Chase & Co. started coverage on shares of Phibro Animal Health in a research report on Tuesday, September 10th. They issued a “neutral” rating and a $22.00 price objective for the company. Three equities research analysts have rated the stock with a sell rating, two have issued a hold rating and one has issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $15.00.

Phibro Animal Health Trading Down 1.2 %

NASDAQ PAHC opened at $24.07 on Friday. The business’s fifty day moving average is $21.13 and its 200-day moving average is $18.26. The company has a debt-to-equity ratio of 1.79, a current ratio of 2.94 and a quick ratio of 1.64. The stock has a market capitalization of $974.84 million, a price-to-earnings ratio of 401.23, a PEG ratio of 0.60 and a beta of 0.52. Phibro Animal Health Co. has a one year low of $9.40 and a one year high of $25.11.

Phibro Animal Health (NASDAQ:PAHC) last released its earnings results on Wednesday, August 28th. The company reported $0.41 earnings per share for the quarter, beating analysts’ consensus estimates of $0.34 by $0.07. Phibro Animal Health had a net margin of 0.24% and a return on equity of 18.08%. The firm had revenue of $273.16 million for the quarter, compared to analysts’ expectations of $262.44 million. Equities research analysts predict that Phibro Animal Health Co. will post 1.55 EPS for the current year.

Phibro Animal Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Wednesday, September 4th were given a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 1.99%. The ex-dividend date was Wednesday, September 4th. Phibro Animal Health’s dividend payout ratio is currently 800.13%.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.